Inventor · disambiguated record
Nis Halland
Also filed as: HALLAND NIS
14 granted patents·7 pending applications·63 citations·filing 2005–2024
88Inventor score
Top patents by PatentIndex Score
21 records- 0193US8735586B2Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazolesALONSO JORGE·Filed 2009·Granted May 27, 2014·34 cites·12 claims
- 0288US8188282B2Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazolesALONSO JORGE·Filed 2009·Granted May 29, 2012·11 cites·20 claims
- 0381US9174993B2N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticalsSANOFI SA·Filed 2012·Granted Nov 3, 2015·8 cites·10 claims
- 0476US10392366B2Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2018·Granted Aug 27, 2019·2 cites·44 claims
- 0576US8026375B2Transition metal catalyzed synthesis of N-aminoindolesSANOFI AVENTIS·Filed 2009·Granted Sep 27, 2011·2 cites·11 claims
- 0674US9896434B2Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2015·Granted Feb 20, 2018·2 cites·14 claims
- 0771US8283476B2Transition metal catalyzed synthesis of 2H-indazolesHALLAND NIS·Filed 2009·Granted Oct 9, 2012·2 cites·1 claims
- 0868US9758520B2Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2016·Granted Sep 12, 2017·1 cites·31 claims
- 0968US2025171427A1Therapeutic compoundsSANOFI SA·Filed 2024·Application pending·0 cites
- 1063US9718825B2N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticalsSANOFI SA·Filed 2014·Granted Aug 1, 2017·1 cites·20 claims
- 1155US9221828B2N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticalsSANOFI SA·Filed 2014·Granted Dec 29, 2015·0 cites·17 claims
- 1255US2010216988A1Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazolesSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 1352US2025243255A1Crf2 receptor agonists and their use in therapySANOFI SA·Filed 2021·Application pending·0 cites
- 1451US8389764B2Urea and sulfamide derivatives as inhibitors of TAFIaKALLUS CHRISTOPHER·Filed 2009·Granted Mar 5, 2013·0 cites·7 claims
- 1550US8420812B2Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonatesRKYEK OMAR·Filed 2009·Granted Apr 16, 2013·0 cites·15 claims
- 1647US2013072493A1N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALSNAZARE MARC·Filed 2011·Application pending·0 cites
- 1746US2016175304A1N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALSSANOFI SA·Filed 2015·Application pending·0 cites
- 1844US8487109B2Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylatesRKYEK OMAR·Filed 2009·Granted Jul 16, 2013·0 cites·14 claims
- 1938US9908868B2Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersSANOFI SA·Filed 2016·Granted Mar 6, 2018·0 cites·42 claims
- 2036US2007276142A1Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl CompoundsHALLAND NIS·Filed 2005·Application pending·0 cites
- 2136US2021170033A1Novel conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing proteinSANOFI SA·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →